{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:00:08Z","timestamp":1761512408006},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.neuropharm.2007.05.012","type":"journal-article","created":{"date-parts":[[2007,5,28]],"date-time":"2007-05-28T07:10:33Z","timestamp":1180336233000},"page":"295-307","source":"Crossref","is-referenced-by-count":30,"title":["Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells"],"prefix":"10.1016","volume":"53","author":[{"given":"M.","family":"Yeste-Velasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Folch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Trull\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Enguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pall\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Camins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.05.012_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0014-5793(99)00685-7","article-title":"Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration","volume":"453","author":"Alvarez","year":"1999","journal-title":"FEBS Letters"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-5618.2002.01150.x","article-title":"Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease","volume":"4","author":"Alvarez","year":"2002","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib3","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1074\/jbc.M408741200","article-title":"The transcription factor NFAT3 mediates neuronal survival","volume":"280","author":"Benedito","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib4","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-4159.2004.02422.x","article-title":"Glycogen synthase kinase 3: a drug target for CNS therapies","volume":"89","author":"Bhat","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib6","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1097\/00001756-200312190-00025","article-title":"Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria","volume":"14","author":"Bijur","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib7","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1523\/JNEUROSCI.18-18-07061.1998","article-title":"Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis","volume":"18","author":"Canu","year":"1998","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ygeno.2004.04.006","article-title":"Gene expression profiles of apoptotic neurons","volume":"84","author":"Cavallaro","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1096\/fj.04-1551fje","article-title":"Glycogen synthase kinase 3beta (GSK3\u03b2) mediates 6-hydroxydopamine-induced neuronal death","volume":"18","author":"Chen","year":"2004","journal-title":"FASEB Journal"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2004.02.029","article-title":"Survival of cultured cerebellar granule cells can be maintained by Akt-dependent and Akt-independent signalling pathways","volume":"127","author":"Chin","year":"2004","journal-title":"Molecular Brain Research"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molbrainres.2005.03.004","article-title":"Inhibition of GSK3\u03b2 is a common event in neuroprotection by different survival factors","volume":"137","author":"Chin","year":"2005","journal-title":"Molecular Brain Research"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1471-4159.2001.t01-1-00251.x","article-title":"Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death","volume":"77","author":"Cross","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib13","doi-asserted-by":"crossref","first-page":"34266","DOI":"10.1074\/jbc.M006160200","article-title":"Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal","volume":"275","author":"Crowder","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib14","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1074\/jbc.M408971200","article-title":"Genes regulated in neurons undergoing transcription-dependent apoptosis belong to signaling pathways rather than the apoptotic machinery","volume":"280","author":"Desagher","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1097-4547(20000101)59:1<24::AID-JNR4>3.0.CO;2-8","article-title":"Caspase-3 is required for apoptosis-associated DNA fragmentation but not for cell death in neurons deprived of potassium","volume":"59","author":"D'Mello","year":"2000","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1124\/mol.104.007062","article-title":"Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells","volume":"67","author":"Enguita","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.20972","article-title":"Lithium-mediated downregulation of PKB\/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells","volume":"115","author":"Erdal","year":"2005","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/00001756-200308060-00012","article-title":"Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity","volume":"14","author":"Facci","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1471-4159.2001.00423.x","article-title":"Attenuation of neurotoxicity in cortical cultures and hippocampal slices from E2F1 knockout mice","volume":"78","author":"Gendron","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1006\/mcne.2001.0962","article-title":"Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis","volume":"17","author":"Gerhardt","year":"2001","journal-title":"Molecular and Cellular Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1242\/jcs.01724","article-title":"p25\/Cdk5 mediated retinoblastoma phosphorylation is an early event in neuronal cell death","volume":"118","author":"Hamdane","year":"2005","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4522(02)00577-8","article-title":"Lithium stimulates progenitor proliferation in cultured brain neurons","volume":"117","author":"Hashimoto","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1471-4159.2003.09799.x","article-title":"A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium","volume":"85","author":"Heidenreich","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib24","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1073\/pnas.0611671104","article-title":"The pRb\/E2F cell-cycle pathway mediates cell death in Parkinson's disease","volume":"104","author":"Hoglinger","year":"2007","journal-title":"Proceedings of the National Academy Science USA"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib25","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1128\/MCB.23.17.6027-6036.2003","article-title":"Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3","volume":"23","author":"Hongisto","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1471-4159.2001.00402.x","article-title":"The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation","volume":"78","author":"Hou","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(01)01909-7","article-title":"Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons","volume":"306","author":"Hou","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2004.11.010","article-title":"Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death","volume":"48","author":"Jin","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochemical Science"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1399-5618.2003.00090.x","article-title":"Lithium prevents colchicine-induced apoptosis in rat cerebellar granule neurons","volume":"6","author":"Jorda","year":"2004","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuroscience.2005.04.061","article-title":"Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium","volume":"134","author":"Jorda","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/JAD-1999-1605","article-title":"Increased cyclin G1 immunoreactivity during Alzheimer's disease","volume":"1","author":"Jordan-Sciutto","year":"1999","journal-title":"Journal of Alzheimers Disease"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnen\/61.4.358","article-title":"Altered distribution of cell cycle transcriptional regulators during Alzheimer disease","volume":"61","author":"Jordan-Sciutto","year":"2002","journal-title":"Journal of Neuropathology Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jnen\/62.1.68","article-title":"Expression patterns of retinoblastoma protein in Parkinson disease","volume":"62","author":"Jordan-Sciutto","year":"2003","journal-title":"Journal Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1399-5618.2002.01179.x","article-title":"Neuroprotective effects of lithium in cultured cells and animal models of diseases","volume":"4","author":"Kanai","year":"2002","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1471-4159.2003.09799.x","article-title":"A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium","volume":"85","author":"Linseman","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib39","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1128\/MCB.24.20.8970-8980.2004","article-title":"Glycogen synthase kinase 3 phosphorylates RBL2\/p130 during quiescence","volume":"24","author":"Litovchick","year":"2004","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0896-6273(01)00495-0","article-title":"Regulation of neuronal survival and death by E2F-1 dependent gene repression and derepression","volume":"32","author":"Liu","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004410100396","article-title":"Neuronal apoptosis at the G1\/S cell cycle checkpoint","volume":"305","author":"Liu","year":"2001","journal-title":"Cell Tissue Research"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1471-4159.2001.00410.x","article-title":"Lithium inhibits caspase 3 activation and dephosphorylation of PKB and GSK3 induced by K+ deprivation in cerebellar granule cells","volume":"78","author":"Mora","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-5618.2002.40301.x","article-title":"Different dependence of lithium and valproate on PI3K\/PKB pathway","volume":"4","author":"Mora","year":"2002","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib44","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/sj.cdd.4401108","article-title":"Cycling at the interface between neurodevelopment and neurodegeneration","volume":"9","author":"Nguyen","year":"2002","journal-title":"Cell Death Differentiation"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib45","doi-asserted-by":"crossref","first-page":"25358","DOI":"10.1074\/jbc.M001725200","article-title":"Induction and modulation of cerebellar granule neuron death by E2F-1","volume":"275","author":"O'Hare","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1471-4159.2003.02015.x","article-title":"Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms","volume":"87","author":"Pardo","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2005.04.052","article-title":"Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells","volume":"58","author":"Shao","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2004.10.082","article-title":"Activity deprivation-dependent induction of the proapoptotic BH3-only protein Bim is independent of JNK\/c-Jun activation during apoptosis in cerebellar granule neurons","volume":"375","author":"Shi","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib49","first-page":"625","article-title":"Induction of DNA replication in adult rat neurons by deregulation of the retinoblastoma\/E2F G1 cell cycle pathway","volume":"11","author":"Smith","year":"2000","journal-title":"Cell Growth Differentiation"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/mcne.2000.0928","article-title":"Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis","volume":"17","author":"Smits","year":"2001","journal-title":"Molecular and Cellular Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jcb.20574","article-title":"E2F1 induces cell death, calpain activation, and MDMX degradation in a transcription independent manner implicating a novel role for E2F1 in neuronal loss in SIV encephalitis","volume":"96","author":"Strachan","year":"2005","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jnr.10318","article-title":"Long-term lithium treatment prevents neurotoxic effects of beta-bungarotoxin in primary cultured neurons","volume":"69","author":"Tseng","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00001756-200203250-00010","article-title":"Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry","volume":"13","author":"Verdaguer","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/JMN:26:1:071","article-title":"Inhibition of multiple pathways accounts for the antiapoptotic effects of flavopiridol on potassium withdrawal-induced apoptosis in neurons","volume":"26","author":"Verdaguer","year":"2005","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.CRJ05009X","article-title":"Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases","volume":"99","author":"Wada","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(00)00127-8","article-title":"Beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment","volume":"392","author":"Wei","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1097-2765(03)00287-9","article-title":"Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation","volume":"12","author":"Welcker","year":"2003","journal-title":"Molecular Cell"},{"key":"10.1016\/j.neuropharm.2007.05.012_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neulet.2004.06.044","article-title":"Indirubin-3\u2032-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons","volume":"367","author":"Xie","year":"2004","journal-title":"Neuroscience Letters"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T07:21:58Z","timestamp":1556436118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0028390807001487"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.05.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}